New study shows that the odds of suffering severe post-operative pain are six times lower with NOL
New study reveals promising findings regarding the ability of Medasense’s NOL monitor to reduce postoperative pain.
New study reveals promising findings regarding the ability of Medasense’s NOL monitor to reduce postoperative pain.
New study reveals promising findings regarding the ability of Medasense’s NOL monitor to reduce postoperative pain.
New study reveals promising findings regarding the ability of Medasense’s NOL monitor to detect pain response levels in ICU patients.
New study shows that effective opioid-sparing anaesthesia with dexmedetomidine can be guided with NOL pain monitoring technology.
Press release: Monitoring pain response levels during surgery with NOL technology can help reduce postoperative pain as well as healthcare costs.
NOL pain response monitoring has been approved for marketing in Brazil.
A new study has found that monitoring pain response levels during surgery with NOL technology can help reduce postoperative pain.
Medasense raises $18M in Series C round
A new economic study has shown that NOL technology is likely to help reduce the cost of care for hospitals.
Medasense Founder and CEO Galit Zuckerman-Stark has been named one of 13 finalists for the EU Prize for Women Innovators 2020.